Merkel cell carcinoma primary sites and overall survival: The prognostic indications of head and neck tumors

Main Article Content

Marcus Elias
Northwell Health

Joshua Burshtein
Victoria Sharon

Keywords

Merkel cell carcinoma, overall survival, head and neck, scalp, national cancer database

References

1. Coggshall K, Tello TL, North JP, Yu SS. Merkel cell carcinoma: An update and review: Pathogenesis, diagnosis, and staging. J Am Acad Dermatol. 2018;78(3):433-442. doi:10.1016/j.jaad.2017.12.001

2. Tarantola TI, Vallow LA, Halyard MY, et al. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol. 2013;68(3):425-432. doi:10.1016/j.jaad.2012.09.036

3. Poulsen M. Merkel cell carcinoma of skin: diagnosis and management strategies. Drugs Aging. 2005;22(3):219-229. doi:10.2165/00002512-200522030-00004

4. Bleicher J, Asare EA, Flores S, Bowles TL, Bowen GM, Hyngstrom JR. Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): A multi-institutional cohort study. The American Journal of Surgery. 2021;221(4):844-849. doi:10.1016/j.amjsurg.2020.08.013

5. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300-2309. doi:10.1200/JCO.2005.02.329

Article Sidebar

PDF
Published
May 13, 2024
DOI https://doi.org/10.25251/skin.8.3.6

Article Details

How to Cite
Elias, M., Burshtein, J., & Sharon, V. (2024). Merkel cell carcinoma primary sites and overall survival: The prognostic indications of head and neck tumors. SKIN The Journal of Cutaneous Medicine, 8(3), 1521–1523. https://doi.org/10.25251/skin.8.3.6
Issue
Vol. 8 No. 3 (2024): May 2024 Issue
Section
Research Letters
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)